[Subjective and objective subtypes of excessive daytime sleepiness in Parkinson's disease].
Clicks: 261
ID: 82845
2019
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
73.0
/100
261 views
209 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Excessive daytime sleepiness (DS) is a common symptom of Parkinson's disease (PD), which can occur at any stage of the disease and decrease the quality of life of patients. The relationship between excessive daytime sleepiness and Parkinson's disease is determined by neurodegenerative process in the brain structures. However, there are many other factors, which can contribute to this phenomenon.To assess the prevalence and causes of DS as well as its impact on the quality of life of patients.Seventy patients (mean age 65.0±8.4 years) with PD, stage I-III, including 48 patients with DS and 22 without DS, were examined. All patients underwent clinical/neurological and neuropsychological examinations using a set of scales and polysomnography, if necessary.Sleep disorders are the most frequent non-motor symptoms of PD. The prevalence of subjective DS is determined for the first time. The disassociation between subjective and objective DS is observed in 32,5% of patients. Clinical combinations of DS with other sleep disorders are described. Taking dopaminergic medication contributes significantly to the development of DS and affective disorders (anxiety, depression) play a role in subjective DS.Reference Key |
iakovleva2019subjectivezhurnal
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
---|---|
Authors | Iakovleva, O V;Poluektov, M G;Lyashenko, E A;Levin, O S; |
Journal | zhurnal nevrologii i psikhiatrii imeni ss korsakova |
Year | 2019 |
DOI | 10.17116/jnevro201911909244 |
URL | |
Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.